PURPOSE: Stable gastric pentadecapeptide BPC 157 accelerates the healing of a transected Achilles tendon and a transected quadriceps muscle. It may also be of clinical relevance as a systemic and local peptide treatment for crush injury of a major muscle, such as gastrocnemius muscle complex. BPC 157 is effective without a carrier, and it is presently undergoing trials for inflammatory bowel disease, and no toxicity has so far been reported. METHODS: In crushed rats (force delivered 0.727 Ns/cm2), BPC 157 was applied either intraperitoneally or locally, as a thin cream layer, immediately after injury (sacrifice at 2 h), and once a day for 14 days. RESULTS: BPC 157 improved muscle healing, macroscopically (less hematoma and edema, no post-injury leg contracture), microscopically, functionally, and also based on enzyme activity (creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase). CONCLUSION: BPC 157, at all investigated intervals, given locally or intraperitoneally, accelerated post-injury muscle healing and also helped to restore the full function.
PURPOSE: Stable gastric pentadecapeptide BPC 157 accelerates the healing of a transected Achilles tendon and a transected quadriceps muscle. It may also be of clinical relevance as a systemic and local peptide treatment for crush injury of a major muscle, such as gastrocnemius muscle complex. BPC 157 is effective without a carrier, and it is presently undergoing trials for inflammatory bowel disease, and no toxicity has so far been reported. METHODS: In crushed rats (force delivered 0.727 Ns/cm2), BPC 157 was applied either intraperitoneally or locally, as a thin cream layer, immediately after injury (sacrifice at 2 h), and once a day for 14 days. RESULTS:BPC 157 improved muscle healing, macroscopically (less hematoma and edema, no post-injury leg contracture), microscopically, functionally, and also based on enzyme activity (creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase). CONCLUSION:BPC 157, at all investigated intervals, given locally or intraperitoneally, accelerated post-injury muscle healing and also helped to restore the full function.
Authors: I Prkacin; J Separovic; G Aralicia; D Perovic; M Gjurasin; M Lovric-Bencic; D Stancic-Rokotov; M Staresinic; T Anic; D Mikus; P Sikiric; S Seiwerth; S Mise; I Rotkvic; V Jagic; R Rucman; M Petek; B Turkovic; A Marovic; B Sebecic; A Boban-Blagaic; N Kokic Journal: J Physiol Paris Date: 2001 Jan-Dec
Authors: P Sikirić; M Petek; R Rucman; S Seiwerth; Z Grabarević; I Rotkvić; B Turković; V Jagić; B Mildner; M Duvnjak Journal: J Physiol Paris Date: 1993
Authors: N Jelovac; P Sikiric; R Rucman; M Petek; A Marovic; D Perovic; S Seiwerth; S Mise; B Turkovic; G Dodig; P Miklic; G Buljat; I Prkacin Journal: Eur J Pharmacol Date: 1999-08-20 Impact factor: 4.432
Authors: Tero A H Järvinen; Teppo L N Järvinen; Minna Kääriäinen; Hannu Kalimo; Markku Järvinen Journal: Am J Sports Med Date: 2005-05 Impact factor: 6.202
Authors: M Staresinic; B Sebecic; L Patrlj; S Jadrijevic; S Suknaic; D Perovic; G Aralica; N Zarkovic; S Borovic; M Srdjak; K Hajdarevic; M Kopljar; L Batelja; A Boban-Blagaic; I Turcic; T Anic; S Seiwerth; P Sikiric Journal: J Orthop Res Date: 2003-11 Impact factor: 3.494
Authors: Predrag Sikiric; Ki-Baik Hahm; Alenka Boban Blagaic; Ante Tvrdeic; Katarina Horvat Pavlov; Andrea Petrovic; Antonio Kokot; Slaven Gojkovic; Ivan Krezic; Domagoj Drmic; Rudolf Rucman; Sven Seiwerth Journal: Gut Liver Date: 2020-03-15 Impact factor: 4.519
Authors: Sven Seiwerth; Marija Milavic; Jaksa Vukojevic; Slaven Gojkovic; Ivan Krezic; Lovorka Batelja Vuletic; Katarina Horvat Pavlov; Andrea Petrovic; Suncana Sikiric; Hrvoje Vranes; Andreja Prtoric; Helena Zizek; Tajana Durasin; Ivan Dobric; Mario Staresinic; Sanja Strbe; Mario Knezevic; Marija Sola; Antonio Kokot; Marko Sever; Eva Lovric; Anita Skrtic; Alenka Boban Blagaic; Predrag Sikiric Journal: Front Pharmacol Date: 2021-06-29 Impact factor: 5.810